Ask AI
ASCENT07 Primary Results
ASCENT-07: Primary Results From Sacituzumab Govitecan vs Chemotherapy as First Post-Endocrine Therapy in HR+/HER2- MBC

Released: December 15, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: December 15, 2025